Floatz logo

Losartan

MPS IV A

Hospital de Clinicas de Porto AlegreSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the MPS IV A cohort.

Asset / SponsorPhaseRating
Bmn 110
BioMarin Pharmaceutical
Phase 3BB

Same molecule, other indications

Losartan is also rated in:

hypertensive disorderDormant
BBB
Indicative ·
76 / 100
View asset →
Cognitively Normal Older AdultsDormant
BB
Indicative ·
66 / 100
View asset →
Subjective Cognitive DeclineDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →